Introduction to the HIV Pill
The partners of those who have HIV can protect themselves from infection through a once-daily pill, two groundbreaking studies in Botswana, Kenya and Uganda have shown. The invention could bring work to combat Aids on the point of a "tipping point", experts say. Attempts to enhance condom utilize to protect against HIV by the hardest-hit parts of the world, and particularly Africa, have hit cultural barriers and had limited success.But now evidently men or women who know – or suspect – their spouse has HIV could protect themselves, secretly if needed. The larger study, involving 4,758 "discordant" couples (where you have HIV but the other has never) in Kenya and Uganda, led by way of the University of Washington's International Clinical Research Centre, has shown that those making a single daily tablet of the Aids drug tenofovir had 62% fewer infections and those that took a pill combining tenofovir and emtricitabine had 73% fewer infections than persons took a placebo pill.The … [Read More...]
African Studies
Two new studies wiped out Africa show that antiretroviral drugs can prevent people from moving the AIDS virus, HIV.The findings in Kenya, Uganda and Botswana show that if HIV-negative people take one pill daily, they could reduce their exposure to infection by up to 73 percent. It’s called pre-exposure prophylaxis (PrEP). The studies were done on couples by which one partner was infected as well as the other haven't been.The findings are “significant on several levels,” said Dr. Cate Hankins, chief scientific advisor to UNAIDS.“We had a signal that this would work that come from the iPrEX trial that reported in November in regards to the utilization of antiretrovirals among men who've got sex with men. And that trial found a 44 percent lowering of risk in males who took this combination tablet. That’s tenofovir / emtricitabine once daily,” she told me.Or a followed by the FemPrEP study on perhaps the regimen would work on women. Still the study was stopped early when … [Read More...]
FDA Approved Pill
The FDA has approved Gilead's Complera, the next complete HIV treatment in an, once-daily pill.Complera is known as a strategy of Truvada (which mixes the nucleoside reverse transcriptase inhibitors Emtriva and Viread) along with the non-nucleoside reverse transcriptase inhibitor Edurant.Truvada has flurished since 2004 which is a preferred constituent of so-called "AIDS drug cocktails" or combination HIV therapy. Edurant, also known as rilpivirine, was approved last May.The initial single-tablet regimen for HIV, Gilead's Atripla, was approved by way of the FDA in 2006. Yet one more single-pill treatment from Gilead, the four-drug Quad, is contained in advanced clinical trials.Complera is approved as a considerate first-line treatment for adults with HIV infection who ve not yet begun treatment with any other HIV medications.It isn't for anyone, as different doctors may prefer to prescribe different HIV drug combinations for other patients. However, the once-daily formulation causes it … [Read More...]
